Antibodies

Monoclonal antibody to microbial transglutaminase



Order
Quantity
Price
Status
200 µg 400 € available


Documents
Art. No. A144
Host Mouse
Clone XM68
Immunogen Microbial Pro-transglutaminase from Streptomyces mobaraensis, recombinantly produced in E. coli (Zedira product No. T016)
Appearance liquid
Description Protein G-affinity purified mouse monoclonal antibody
Formulation 0.1M PBS + 0.02% Na azide
Application Western-Blotting, Immunofluorescence
Working dilutions Optimal dilutions should be determined by the end user.
E.g. for Western-Blotting or ELISA: 1 / 500 to 1 / 5,000 should be suitable
Storage Refrigerate at +2°C to +8°C for not longer than 10 months.
Store frozen at -20°C or below for longer period.
Delivery is possible at ambient temperature
Note INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.

Products

  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.

News  

  • Dr. Falk Pharma and Zedira announce start of the phase 2b real-life study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
  • imageReversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
  • imagePress release: Zedira announces ISO 9001:2015 certification

Blog  

  • DZG Aktuell: „Aufruf zur Teilnahme an einer weiteren Wirksamkeitsstudie mit dem Studienmedikament ZED1227“
  • imageDesign of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
  • imageMicrobial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering

Events  

  • Gordon Research Conference: Transglutaminases in Human Disease Processes

    12.06.2022 - 17.06.2022
    Mount Snow, USA

  • 19th International Celiac Disease Symposium

    19.10.2022 - 22.10.2022
    Sorrento, Italy